Biomedoz to close
Wednesday, 16 July, 2003
Online industry and share market watcher Biomedoz has called it a day. Last week, the site posted a note informing users that it would close "in the next couple of days".
Editor Bengt Norrman lamented the lack of interest realised by the site, from both industry and stakeholders. He described the last four years as "both fun and hard graft", but admitted that the company had failed to elicit a suitable partner to help fund the site and undertake further development.
"Philanthropy and love of the industry started Biomedoz," wrote Norrman. "Indifference and the hard cold facts of today's business environment brought it down. Perhaps there is one piece of hard-earned wisdom that we can share with you: philanthropy and business do not mix very well," he added.
$96m RNA Research and Manufacturing Facility opens in NSW
The new 4500 sqm RNA Research and Manufacturing Facility within the Macquarie University...
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
Alliance seeks to boost regional capacity in clinical trials
Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...
